Form 8-K · Current report
Citizens Financial Group 8-K, filed Jul 21, 2026
- Filed
- CIK
- 0000759944
- Accession no.
- 0000759944-26-000139
Summary
Citizens Financial Group announced second quarter 2026 earnings with net income of $587 million and diluted EPS of $1.30, and declared a quarterly common dividend of $0.46 per share. It also announced a proposed public offering of Series J preferred stock, whose proceeds, if the offering prices and closes, would be used to redeem some or all of its Series G preferred stock on October 6, 2026, subject to market conditions.
Key points
- Citizens Financial Group reported second quarter 2026 net income of $587 million, diluted EPS of $1.30, and ROTCE of 13.9%.
- Its board declared a quarterly common stock dividend of $0.46 per share, payable on August 13, 2026, to shareholders of record as of July 30, 2026.
- Citizens announced a proposed public offering of a new series of Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series J, subject to pricing.
- If the offering prices and closes, Citizens intends to use net proceeds to redeem some or all of its 4.000% Series G Preferred Stock on October 6, 2026, subject to market conditions.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. On July 16, 2026, Citizens Financial Group, Inc. (the “Company”) announced its second quarter 2026 earnings. The Company’s earnings results and financial supplement are being filed as Exhibits 99.1 and 99.2, respectively. On July 21, 2026, the Company announced the launch of a proposed public offering (the “Offering”) of a new series of Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series J (the “Series J Preferred Stock”). The Offering is subject to pricing, which has not yet occurred. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.